PMC:7291971 / 446-894
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T12 | 49-59 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T13 | 184-191 | NCBITaxon:10239 | denotes | viruses |
| T14 | 347-357 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T15 | 423-426 | GO:0008541 | denotes | cap |
| T93340 | 49-59 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T49466 | 184-191 | NCBITaxon:10239 | denotes | viruses |
| T50627 | 347-357 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T65425 | 423-426 | GO:0008541 | denotes | cap |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T5 | 214-217 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T6 | 427-430 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 184-191 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T6 | 39-48 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T7 | 49-59 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T8 | 299-308 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T9 | 347-357 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 404-415 | http://purl.obolibrary.org/obo/GO_0032259 | denotes | methylation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 2-140 | Sentence | denotes | The discovery of potent and specific antiviral inhibitors and/or vaccines to fight these massive outbreaks is an urgent research priority. |
| T6 | 141-322 | Sentence | denotes | Enzymes involved in the capping pathway of viruses and more specifically RNA N7- or 2′O-methyltransferases (MTases) are now admitted as potential targets for antiviral chemotherapy. |